“High Prevalence of GHD Disorders & Patent Expiries Drive Demand for Human Growth Hormone Drugs”

“High Prevalence of GHD Disorders & Patent Expiries Drive Demand for Human Growth Hormone Drugs”

© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved

For more details

June 2014 ReleaseJune 2014 Release

© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved

Global market for Human Growth Hormone (hGH) Drugs is forecast to reach US$3.8 billion by 2020, spurred by progressive increase in the prevalence of growth hormone deficiency diseases, and emergence of novel drug formulations and drug-delivery systems. Rare pediatric growth hormone deficiency disorders (GHD), such as, Idiopathic Short Stature, Noonan Syndrome, Prader-Willi Syndrome, Turner Syndrome, and Short Stature Homeobox Gene continue to remain the main therapeutic indication for hGH drugs. Growth in Asia-Pacific, the fastest growing market, is led by factors such as population growth, increased healthcare spending, favorable regulatory scenario, and increasing accessibility and affordability of hGH drugs and therapies.

• Eli Lilly and Company

• Ferring Holding SA

• Genentech Inc.

• GeneScience Pharmaceuticals Co. Ltd.

• Merck Serono SA

• Novo Nordisk A/S

• Pfizer Inc.

• Sandoz International GmbH

• Teva Pharmaceutical Industries

Limited

Major Players…US$3.8 Billion

2014 2015 2016 2017 2018 202020192013

© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved

• High Prevalence of GHD Disorders Drives

Demand for hGH Drugs

• Patent Expiry Paves Way for the

Emergence of Biosimilars

• Untapped Adult Growth Hormone

Deficiency Market to Witness Strong

Growth

• Long-Acting hGH Drugs: A Potential Game

Changer

• Rapid Adoption of hGH Replacement

Therapy: A Key Growth Driver

• Biobetters Restrict the Presence of

Biosimilars

Snapshot Summary of Trends & Drivers

• The United States represents the largest

regional market worldwide, while Asia-

Pacific ranks as the fastest growing

market with a CAGR of 4.4% over the

analysis period.

USA

© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved

GIA’s Actionable Research Insights

Market Analytics Market Profiling Competitive Intelligence

• Estimates and Forecasts for 2013-2020

• Historic Review for 2006-2012

• Geographic Regions Analyzed - The United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia-Pacific, and Rest of World.

• Drug Brands Analyzed - Norditropin, Genotropin, Humatrope, Nutropin, Saizan, and Others.

• Market Trends & Issues

• Growth Drivers & Enablers

• Growth Inhibitors

• Opportunities and Challenges

• Recent Industry Activity

• Product Innovations & Trends

• Market Analyses, Facts,

Figures & Forecasts

• Coverage of Major & Niche

Players

• Comprehensive Geographic

Coverage

• 30 major and niche players covered

To browse full report table of contents, please

© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.Telephone: 408-528-9966Fax: 408-528-9977 Email: press@StrategyR.comWeb Site: http://www.strategyr.com/

© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved

The research report titled “Human Growth Hormone Drugs: A Global Strategic Business Report”

published by Global Industry Analysts, Inc., is now available for purchase online. To view report

excerpts and the full table of contents (TOC) and to sign up for a comprehensive complimentary

review of our research program including details on methodology, secondary and primary sources

and summary of research findings, please visit –

http://www.strategyr.com/Human_Growth_Hormone_Drugs_Market_Report.asp